| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD1835 | CTRPv2 | pan-cancer | AAC | -0.0094 | 0.8 |
| mRNA | Merck60 | CTRPv2 | pan-cancer | AAC | 0.0075 | 0.8 |
| mRNA | WAY-362450 | CTRPv2 | pan-cancer | AAC | 0.0092 | 0.8 |
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | 0.0081 | 0.8 |
| mRNA | blebbistatin | CTRPv2 | pan-cancer | AAC | -0.018 | 0.8 |
| mRNA | AGK-2 | CTRPv2 | pan-cancer | AAC | 0.0091 | 0.8 |
| mRNA | temsirolimus | FIMM | pan-cancer | AAC | 0.04 | 0.8 |
| mRNA | Salubrinal | GDSC1000 | pan-cancer | AAC | -0.013 | 0.8 |
| mRNA | Bortezomib | GDSC1000 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | SB-431542 | CTRPv2 | pan-cancer | AAC | 0.0087 | 0.8 |